Tackling acute myeloid leukemia via diverse pathways
Tackling acute myeloid leukemia via diverse path
New options in untreated and pretreated mantle cell lymphoma
New options in untreated and pretreated mantle c
Prolonging remission in relapsed and refractory follicular lymphoma
Prolonging remission in relapsed and refractory
BTK inhibition in Waldenström’s macroglobulinemia: trial updates and real-world insights
BTK inhibition in Waldenström’s macroglobulinemi
Early-phase trials investigating novel agents in miscellaneous B-cell malignancies
Early-phase trials investigating novel agents in
Marginal zone lymphoma: benefits of BTK inhibition in later lines
Marginal zone lymphoma: benefits of BTK inhibiti
Updates and ancillary analyses in the setting of chronic lymphocytic leukemia
Updates and ancillary analyses in the setting of
Preface – EHA 2022
Preface – EHA 2022 Matthew S. Davids, M
Roger Owen
ASCO/EHA/ICML 2021 – Roger Owen Roger Owen summar
Christian Buske
ASCO/EHA/ICML 2021 - Christian Buske Christian Bu
